| Catherine Brooke Tompkins, OTD, OTR/L | |
|
1951 Bluegrass Cir, Cheyenne, WY 82009-7355 | |
| (307) 773-8533 | |
| (307) 635-7578 |
| Full Name | Catherine Brooke Tompkins |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1951 Bluegrass Cir, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730964248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT-1718 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Brooke Tompkins, OTD, OTR/L 1951 Bluegrass Cir, Cheyenne, WY 82009-7355 Ph: (307) 773-8533 | Catherine Brooke Tompkins, OTD, OTR/L 1951 Bluegrass Cir, Cheyenne, WY 82009-7355 Ph: (307) 773-8533 |
News Archive
One of the great questions of neurobiology, how the brain is built up during embryonic development, could be resolved by a young French scientist in an award winning project organised by the European Science Foundation (ESF) and the European Heads of Research Councils (EuroHORCS).
Ironwood Pharmaceuticals, Inc. today announced that the underwriters of its February 2, 2010 initial public offering (IPO) have exercised their over-allotment option in full on an additional 2.5 million shares of Ironwood's Class A common stock. With the completion of the IPO and the exercise of the over-allotment option, Ironwood has approximately 97.4 million shares of common stock outstanding (approximately 19.2 million shares of Class A common stock and 78.2 million shares of Class B common stock).
Diagnostic Hybrids, a Quidel Company, received approval from the People's Republic of China's State Food and Drug Administration (SFDA) for its D3 Ultra DFA Respiratory Virus Screening and ID Kit. The D3 Ultra DFA Respiratory Virus Screening and ID Kit is a direct fluorescence assay (DFA) that provides rapid, sensitive and specific screening and identification of Influenza A, Influenza B, Parainfluenza 1, 2, & 3, Respiratory Syncytial Virus and Adenovirus.
A study in Neurology suggests that analyzing levels of the protein p75ECD in urine samples from people with amyotrophic lateral sclerosis (ALS) may help monitor disease progression as well as determine the effectiveness of therapies.
› Verified 8 days ago
Ms. Jackie Renee Thatcher, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4735 Maple Way, Cheyenne, WY 82009 Phone: 307-635-7605 | |
Erica Kaylynne Strautman, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 903 S Greeley Hwy Ste B, Cheyenne, WY 82007 Phone: 307-634-2109 Fax: 307-683-4005 | |
Kaitlin Brew, MOTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4606 N College Dr, Cheyenne, WY 82009 Phone: 307-414-8394 Fax: 307-316-8125 | |
Amanda Dawn Scott, O.T.R Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5801 Yellowstone Rd, Cheyenne, WY 82009 Phone: 307-638-6100 | |
Sherri Dawn Strohman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3718 Pioneer Ave, Cheyenne, WY 82001 Phone: 307-630-5274 | |
Angie Lea Crotser, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 | |
Kenna Lynn Kacillas, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3128 Boxelder Dr, Cheyenne, WY 82001 Phone: 307-634-7901 |